Literature DB >> 24256046

Prevalence of GJB2 mutations in the Silk Road region of China and a report of three novel variants.

Wan Du1, Yi Ming Zhu, Yu Fen Guo, Qiu Ju Wang, Xiao Wen Liu.   

Abstract

CONCLUSION: The c.235delC of GJB2 gene is the hotspot mutation of the hearing loss population in the Silk Road region of China. It is high time that some active interventions (such as hearing aids or cochlear implant) are provided to improve their language ability and quality of life.
OBJECTIVES: The first gene to be identified for humans with nonsyndromic hearing loss was GJB2 gene. We investigated the prevalence of GJB2 mutations in the Silk Road region of China to study the mutation spectrum in this area.
METHODS: Bidirectional sequencing was carried out for all PCR products of samples. The statistical analysis was carried out using SAS 9.0.1 software.
RESULTS: Pathogenic mutations were identified in 243 of 2398 patients, including 168 homozygous mutations and 75 compound heterozygous mutations. Three variants (c.225G>T, c.521G>A, and c.557C>T) are novel mutations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24256046     DOI: 10.3109/00016489.2013.849817

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Prevalence of mutations in GJB2, SLC26A4, and mtDNA in children with severe or profound sensorineural hearing loss in southwestern China.

Authors:  Jie Qing; Yuan Zhou; Ruosha Lai; Peng Hu; Yan Ding; Weijing Wu; Zian Xiao; Phi T Ho; Yuyuan Liu; Jia Liu; Lilin Du; Denise Yan; Bradley J Goldstein; Xuezhong Liu; Dinghua Xie
Journal:  Genet Test Mol Biomarkers       Date:  2015-01

2.  Case report: Novel GJB2 variant c.113T>C associated with autosomal recessive non-syndromic hearing loss (ARNSHL) in a Han family.

Authors:  Xinqiang Lan; Shiyu Sun; Xin Lan; Linyuan Niu; Chunxiao Zhang; Xiaoli Chen; Ningning Xia
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.